Literature DB >> 12496060

Dietary soy and increased risk of bladder cancer: the Singapore Chinese Health Study.

Can-Lan Sun1, Jian-Min Yuan, Kazuko Arakawa, Siew-Hong Low, Hin-Peng Lee, Mimi C Yu.   

Abstract

The association between soyfood consumption and subsequent bladder cancer risk was investigated in a population-based cohort study, the Singapore Chinese Health Study. As of December 31, 2000, 329,848 person-years of follow-up were accrued. Sixty-one histologically confirmed incident bladder cancer cases were identified. Information on soyfood consumption at baseline was obtained through in-person interviews using a validated dietary questionnaire. Relative risks and 95% confidence intervals were calculated using the Cox proportional hazard regression method. High intake of soyfood was statistically significantly related to an elevated risk of bladder cancer. Relative to the lowest quartile of energy-adjusted total soy intake (<36.9 g/1000 Kcal), the highest quartile of total soy intake (> or =92.5 g/1000 Kcal) was associated with a 2.3-fold increase in bladder cancer risk (95% confidence interval = 1.1-5.1) after adjustment for cigarette smoking and level of education. Similar results were obtained for intakes of soy protein and soy isoflavones. The soyfood-bladder cancer risk association did not differ significantly between men and women and was not explained by other dietary factors. The soy-cancer relationship became stronger when the analysis was restricted to subjects with longer (> or =3 years) duration of follow-up. To our knowledge, this is the first epidemiological report on the effect of dietary soy on bladder cancer risk.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12496060

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  16 in total

1.  Combined effects of MDM2 SNP309 and TP53 R72P polymorphisms, and soy isoflavones on breast cancer risk among Chinese women in Singapore.

Authors:  Woon-Puay Koh; David Van Den Berg; Aizhen Jin; Renwei Wang; Jian-Min Yuan; Mimi C Yu
Journal:  Breast Cancer Res Treat       Date:  2011-07-21       Impact factor: 4.872

2.  Soy protein: the next antihypertensive agent?

Authors:  Ana M Cartagena
Journal:  CMAJ       Date:  2005-08-30       Impact factor: 8.262

3.  Prospective study of dietary patterns and persistent cough with phlegm among Chinese Singaporeans.

Authors:  Lesley M Butler; Woon-Puay Koh; Hin-Peng Lee; Marilyn Tseng; Mimi C Yu; Stephanie J London
Journal:  Am J Respir Crit Care Med       Date:  2005-10-20       Impact factor: 21.405

Review 4.  Adverse effects of plant food supplements and botanical preparations: a systematic review with critical evaluation of causality.

Authors:  Chiara Di Lorenzo; Alessandro Ceschi; Hugo Kupferschmidt; Saskia Lüde; Elizabeth De Souza Nascimento; Ariana Dos Santos; Francesca Colombo; Gianfranco Frigerio; Karin Nørby; Jenny Plumb; Paul Finglas; Patrizia Restani
Journal:  Br J Clin Pharmacol       Date:  2015-04       Impact factor: 4.335

5.  A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients.

Authors:  Edward Messing; Jason R Gee; Daniel R Saltzstein; KyungMann Kim; Anthony diSant'Agnese; Jill Kolesar; Linda Harris; Adrienne Faerber; Thomas Havighurst; Jay M Young; Mitchell Efros; Robert H Getzenberg; Marcia A Wheeler; Joseph Tangrea; Howard Parnes; Margaret House; J Erik Busby; Raymond Hohl; Howard Bailey
Journal:  Cancer Prev Res (Phila)       Date:  2012-01-31

6.  Soy components vs. whole soy: are we betting our bones on a long shot?

Authors:  Susan Reinwald; Connie M Weaver
Journal:  J Nutr       Date:  2010-10-27       Impact factor: 4.798

7.  Soy food consumption and lung cancer risk: a meta-analysis using a common measure across studies.

Authors:  Sheng Hui Wu; Zhong Liu
Journal:  Nutr Cancer       Date:  2013       Impact factor: 2.900

8.  Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis.

Authors:  Ajita V Singh; Adrian A Franke; George L Blackburn; Jin-Rong Zhou
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

9.  Chemoprevention in bladder cancer: What's new?

Authors:  Jean-Baptiste Lattouf
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

10.  Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation.

Authors:  Jian Teng; Zun-Yi Wang; David F Jarrard; Dale E Bjorling
Journal:  Endocr Relat Cancer       Date:  2008-03       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.